Strong Revenue and EBITDA Growth
Revenue for the nine-month period grew over 13% year-over-year, reaching BRL 2.784 billion. Adjusted EBITDA grew by almost 19% year-over-year, reaching BRL 1.292 billion, with an adjusted EBITDA margin increase of 200 basis points to 46.4%.
Record Cash Flow and Income
Cash flow from operating activities increased by 11% to BRL 1.292 billion, with a cash conversion of 101.5%. Net income grew by 20% year-over-year to BRL 593 million, with a basic EPS increase of 20% to BRL 6.40.
Leadership in Medical Education
Afya maintained 100% occupancy in all medical programs, with approved medical seats growing to 3,753. The number of undergraduate medical students rose by 6%.
Significant ESG Achievements
Delivered 700,000 free healthcare consultations and was recognized by Valor Econômico as the top-performing company in the Brazilian education sector for the fourth consecutive year.
Successful Financial Strategy
Afya strengthened financial positions through liability management, issuing commercial notes totaling BRL 1.5 billion and maintaining a low cost of debt at 106% of the CDI.